AstraZeneca: Despite worrying briefing documents, lesinurad gets positive recommendation from AdCom

BUY, Fair Value  5100p (+25%)
News published on October Monday 26, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities